INHALER PARTICULARLY A CANNABINOID INHALER AND A METHOD OF ASSEMBLING SUCH AN INHALER
20200282159 ยท 2020-09-10
Inventors
Cpc classification
A61M15/0093
HUMAN NECESSITIES
A61M11/02
HUMAN NECESSITIES
A61M15/06
HUMAN NECESSITIES
A61M16/20
HUMAN NECESSITIES
International classification
A61M15/06
HUMAN NECESSITIES
Abstract
An inhaler comprising an inner housing (1) with a pressurised reservoir of an inhalable composition. A breath operated valve (5) is operable by a user inhaling on an inhaling end of the inhaler. A composition flow path extends from the breath operated valve (5) to the inhaling end via which the composition is dispensed when the breath operated valve is opened. The breath operated valve (5) is biased closed by a biasing member contacting the breath operated valve at one end. A bung (16) in the inner housing is positioned in an opening in the inner housing to support the end of the biasing member (8) opposite to the breath operated valve. A rigid outer housing (3) surrounds the inner housing and supports the bung (16).
Claims
1. An inhaler comprising an inner housing with a pressurised reservoir of an inhalable composition; a breath operated valve operable by a user inhaling on an inhaling end of the inhaler; a composition flow path from the breath operated valve to the inhaling end via which the composition is dispensed when the breath operated valve is opened; the breath operated valve being biased closed by a biasing member contacting the breath operated valve at one end; a bung in the inner housing, the bung being positioned in an opening in the inner housing to support the end of the biasing member opposite to the breath operated valve; and a rigid outer housing surrounding the inner housing and supporting the bung.
2. An inhaler according to claim 1 , wherein the inhalable composition comprises a cannabinoid or a pharmaceutically acceptable derivative or salt thereof.
3. An inhaler according to claim 1, further comprising a membrane which is in communication with an air flow path through the inhaler leading to the inhaling end, the membrane being configured to be deformable by air in the air flow path to displace a valve element against the action of the biasing member.
4. An inhaler according to claim 1, further comprising a cap which forms part of the inner housing adjacent to the biasing member, a hole being provided in the cap to receive the bung.
5. An inhaler according to claim 1, wherein the outer housing is formed of a number of components which are attached in a non-welded manner.
6. An inhaler according to claim 5, wherein the components are clipped together.
7. An inhaler according to claim 6, wherein the components are irreversibly clipped together.
8. A method of assembling an inhaler according to claim 4, the method comprising the steps of attaching the cap to the remainder of the inner housing; inserting the biasing member through the hole in the cap; attaching the bung to the cap in order to secure the biasing member in place; and assembling the outer housing to support the bung.
9. A cannabinoid inhaler comprising an inner housing; a pressurised reservoir within the inner housing containing an inhalable composition comprising a cannabinoid or pharmaceutically acceptable derivative or salt thereof, a composition flow path from the reservoir and out of a composition outlet at an inhaling end of the inner housing; a non-metered breath operated outlet valve for controlling the flow of the inhalable composition through the composition flow path; a refill valve via which the reservoir can be refilled; and an outer housing surrounding the inhaler housing leaving the inhaling end of the inhaler housing exposed; the outer housing having a main axis defining a longitudinal direction and in at least one cross section in a plane perpendicular to the longitudinal axis, a continuously curved flattened shape with a width to depth aspect ratio of greater than 1.2 and a maximum width of greater than 20 mm.
10. An inhaler according to claim 9 wherein the flattened shape comprising opposing flat surfaces, wherein at least one of the flat surfaces comprises a recess which extends for at least one third of the length of the inhaler and at least one third of the width of the inhaler.
11. An inhaler according to claim 10, wherein the recess extends for at least half of the length of the reservoir.
12. An inhaler according to claim 10, wherein the recess extends for at least half of the width of the inhaler.
13. An inhaler according to claim 10, wherein the depth of the recess is greater than 10% of the depth of the inhaler.
14. An inhaler according to claim 10, wherein each of the flat surfaces comprise a respective recess.
15. The combination of a cannabinoid inhaler and a refill pack; the cannabinoid inhaler comprising a housing; a pressurised reservoir within the housing containing an inhalable composition comprising a cannabinoid or pharmaceutically acceptable derivative or salt thereof, a composition flow path from the reservoir and out of a composition outlet at an inhaling end of the housing; a non-metered breath operated outlet valve for controlling the flow of the inhalable composition through the composition flow path; a refill valve via which the reservoir can be refilled; the refill pack comprising a housing having a recess to retain the inhaler, a pressurised canister of an inhalable composition, and a closable door to enclose the inhaler; wherein the door is held closed by a respective latch at each end of the housing, each latch being operable by depressing a portion of the housing inwardly into the housing, the latches is being at least 80 mm apart.
16. A combination according to claim 15 wherein the latches are at least 90 mm apart.
17.-21. (canceled)
Description
[0037] Examples of the various aspects of the present invention will now be described with reference to the accompanying drawings, in which:
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047] The present invention comprises an inhaler device 1 shown in
[0048] The internal workings of the inhaler device 1 are based on an inhaler I which is described in all of the PCT publications referred to above. This forms the inner core of the present invention. The modification provided by the present invention is, in broad terms, to surround this inner core I with an outer housing 3 as described below.
[0049] In general terms, the workings of the inhaler I have not been modified and this will therefore not be described in great detail here.
[0050] In broad terms, the inhaler core comprises a reservoir 4 and a breath operated valve mechanism 5 which has a spring loaded member valve member 6 (see
[0051] The inhaler core also has a dip tube 11 which is held by a fixture 12 adjacent to a refill valve 13. This allows the inhaler I to be refilled at the refill end 14. Again, further details can be found in the above mentioned references.
[0052] One modification to the inhaler I is illustrated in
[0053] As is apparent, for example, from
[0054] The inhaler core I is also held in place within the outer housing 3 by the presence of an elongate rib 26 which extends along a significant portion of the length of the inhaler I and engages with a corresponding slot in the outer housing 3 to retain the inhaler I in place.
[0055] As shown particularly in
[0056] Thus, the outer housing 3 is provided with a significantly larger size than the inhaler core as can be seen, for example, from
[0057] When the inhaler device 1 needs to be refilled, the refill end 33 is inserted into the refill pack 2 as described below. The recesses 30 provide a pair of surfaces 34 that can readily be gripped by a user and which are oriented such that a user can readily exert a pushing force urging the refill end 33 into the refill pack as described below.
[0058] The refill pack 2 will now be described with reference to
[0059] The refill pack 2 has a housing 40 with an openable door 41 as shown in
[0060] The body of the housing 40 other than the door 41 is provided by two parts 45, 46 which are welded (eg. by sonic welding) along line 47 to encapsulate the canister 43. The canister 43 can therefore not be removed without destroying the housing 40. The parts can alternatively be clipped together in an irreversible manner.
[0061] A window 48 is provided in the housing 40 on both sides of the nozzle 44 so that a user can see when the refill end 33 of the inhaler device 1 is inserted into a recess 49 surrounding the nozzle 44. The recess 49 has a shape which is complimentary to the shape of the refill end 33 such that, not only can the user see the refill end being guided onto the refill nozzle 44, this is also guided by the interaction of the refill end 33 and the recess 49.
[0062] The door 41 is attached to the main body of the housing 40 by a pair of hinges 50 to allow the door 41 to be hinged between the closed position shown in
[0063] A pair of latches 53 are provided one at each end of the door 41. Each comprises a hook 54 which is resiliently deformable to engage in a respective aperture 55 in the casing 40 and a release component 56 clearly marked with a visible arrow which has textured surface to allow the user to readily locate an engage with the release component 56. A notch 57 is provided in the door 40 in the vicinity of the release component 56 such that the release component 56 is deflectable inwardly of the housing to release the hook 54 from the aperture 55 thereby allowing the door to be opened. The latches 53 are deliberately positioned one at each end of the device, which has a length of approximately 100 mm such that they spaced apart by a distance which cannot be opened by a child holding the device in a single hand. They can, however, readily be opened by an adult sized hand.
[0064] As will be apparent from
[0065] While certain claims specify a cannabinoid inhaler and require an inhalable composition comprising a cannabinoid, all aspects of the invention can be used with any inhalable pharmaceutical composition.